Ontology highlight
ABSTRACT:
SUBMITTER: Millard J
PROVIDER: S-EPMC6005026 | biostudies-literature | 2018 Jul
REPOSITORIES: biostudies-literature
Millard James J Pertinez Henry H Bonnett Laura L Hodel Eva Maria EM Dartois Véronique V Johnson John L JL Caws Maxine M Tiberi Simon S Bolhuis Mathieu M Alffenaar Jan-Willem C JC Davies Geraint G Sloan Derek J DJ
The Journal of antimicrobial chemotherapy 20180701 7
<h4>Objectives</h4>The oxazolidinone linezolid is an effective component of drug-resistant TB treatment, but its use is limited by toxicity and the optimum dose is uncertain. Current strategies are not informed by clinical pharmacokinetic (PK)/pharmacodynamic (PD) data; we aimed to address this gap.<h4>Methods</h4>We defined linezolid PK/PD targets for efficacy (fAUC0-24:MIC >119 mg/L/h) and safety (fCmin <1.38 mg/L). We extracted individual-level linezolid PK data from existing studies on TB pa ...[more]